<?xml version="1.0" encoding="UTF-8"?>
<!--CIMG V1.1 (21-04-2026)-->
<xbrli:xbrl xmlns:in-capmkt="http://www.sebi.gov.in/xbrl/2025-11-30/in-capmkt" xmlns:in-capmkt-ent="http://www.sebi.gov.in/xbrl/Changes_In_Management/2025-11-30/in-capmkt/in-capmkt-ent" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:in-capmkt-types="http://www.sebi.gov.in/xbrl/2025-11-30/in-capmkt-types" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.w3.org/1999/xlink"><link:schemaRef xlink:type="simple" xlink:href="in-capmkt-ent-2025-11-30.xsd"/><xbrli:context id="MainD"><xbrli:entity><xbrli:identifier scheme="https://www.sebi.gov.in/in-capmkt/ScripCode">543350</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-07-09</xbrli:startDate><xbrli:endDate>2026-07-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="MainI"><xbrli:entity><xbrli:identifier scheme="https://www.sebi.gov.in/in-capmkt/ScripCode">543350</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-07-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="I_ChangeInManagement1"><xbrli:entity><xbrli:identifier scheme="https://www.sebi.gov.in/in-capmkt/ScripCode">543350</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-07-09</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:ChangeInManagementAxis"><in-capmkt:ChangeInManagementDomain>ChangeInManagementDomain1</in-capmkt:ChangeInManagementDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="D_ChangeInManagement1"><xbrli:entity><xbrli:identifier scheme="https://www.sebi.gov.in/in-capmkt/ScripCode">543350</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-07-09</xbrli:startDate><xbrli:endDate>2026-07-09</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:ChangeInManagementAxis"><in-capmkt:ChangeInManagementDomain>ChangeInManagementDomain1</in-capmkt:ChangeInManagementDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:unit id="pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><in-capmkt:NSESymbol contextRef="MainI">VIJAYA</in-capmkt:NSESymbol><in-capmkt:NameOfTheCompany contextRef="MainI">VIJAYA DIAGNOSTIC CENTRE LIMITED</in-capmkt:NameOfTheCompany><in-capmkt:ScripCode contextRef="MainI">543350</in-capmkt:ScripCode><in-capmkt:MSEISymbol contextRef="MainI">NOTLISTED</in-capmkt:MSEISymbol><in-capmkt:ISIN contextRef="MainI">INE043W01024</in-capmkt:ISIN><in-capmkt:WhetherDisclosureFiledForListedEntity contextRef="MainD">true</in-capmkt:WhetherDisclosureFiledForListedEntity><in-capmkt:RelationshipWithTheListedEntity contextRef="MainD">Listed Entity (self)</in-capmkt:RelationshipWithTheListedEntity><in-capmkt:WhetherEventOrInformationIsAnOutcomeOfBoardMeeting contextRef="MainD">true</in-capmkt:WhetherEventOrInformationIsAnOutcomeOfBoardMeeting><in-capmkt:DateOfBoardMeeting contextRef="MainD">2026-07-09</in-capmkt:DateOfBoardMeeting><in-capmkt:StartTimeOfBoardMeeting contextRef="MainD">17:30:00</in-capmkt:StartTimeOfBoardMeeting><in-capmkt:EndTimeOfBoardMeeting contextRef="MainD">17:40:00</in-capmkt:EndTimeOfBoardMeeting><in-capmkt:NumberOfPersonsOrEntitiesForWhomChangeIsBeingReported contextRef="MainI" unitRef="pure" decimals="0">1</in-capmkt:NumberOfPersonsOrEntitiesForWhomChangeIsBeingReported><in-capmkt:DateOfReport contextRef="MainI">2026-07-09</in-capmkt:DateOfReport><in-capmkt:TypeOfChange contextRef="D_ChangeInManagement1">Appointment</in-capmkt:TypeOfChange><in-capmkt:CategoryForChange contextRef="D_ChangeInManagement1">Key Managerial Personnel</in-capmkt:CategoryForChange><in-capmkt:DesignationOfDesignatedPerson contextRef="D_ChangeInManagement1">Chief Financial Officer</in-capmkt:DesignationOfDesignatedPerson><in-capmkt:SalutationOfDesignatedPerson contextRef="D_ChangeInManagement1">Mr.</in-capmkt:SalutationOfDesignatedPerson><in-capmkt:NameOfDesignatedPerson contextRef="I_ChangeInManagement1">Narasimha Raju K.A.</in-capmkt:NameOfDesignatedPerson><in-capmkt:EffectiveDateOfReasonOfChange contextRef="I_ChangeInManagement1">2026-07-09</in-capmkt:EffectiveDateOfReasonOfChange><in-capmkt:BriefProfile contextRef="D_ChangeInManagement1">
Mr. Narasimha Raju K A is a Chartered Accountant and an accomplished Chief Financial Officer with over 20 years of extensive experience in finance, accounting, corporate governance, and strategic leadership. He combines a strong foundation in Big Four audit, having worked with S R Batliboi &amp; Co (an affiliate of Ernst &amp; Young), with senior leadership experience across the healthcare, diagnostics, renewable energy, and real estate sectors. 

Mr. Narasimha Raju was also the CFO of our Company during March 15, 2021 to March 26, 2025. Throughout his career, he has successfully led several high-impact strategic initiatives, including initial public offerings (IPOs), Draft Red Herring Prospectus (DRHP), investor relations, mergers and acquisitions, group restructurings, and regulatory compliance for both listed companies and private equity-backed organizations. He is recognized for executing complex capital market transactions within challenging timelines, including the successful completion of our Company’s IPO during the COVID-19 pandemic, while strengthening corporate governance frameworks in alignment with Board and Audit Committee expectations.

His areas of expertise include investor relations and stakeholder management, mergers, acquisitions and demergers, private equity, financial reporting and consolidation under Ind AS and IFRS, Board and Audit Committee governance, tax structuring and cross-border transactions, budgeting, management information systems (MIS) and performance management, risk management and internal controls, as well as regulatory, secretarial, and statutory compliances.

Prior to rejoining the Company now, Mr. Narasimha Raju served as the Chief Financial Officer of Yashoda Group of Hospitals. 

Mr. Narasimha Raju's rich professional experience, strong financial acumen, and proven leadership in corporate finance, governance, and strategic transactions is expected to further strengthen the Company's financial management, governance standards, and long-term strategic objectives.
</in-capmkt:BriefProfile></xbrli:xbrl>
